Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest
- 1 July 2001
- journal article
- Published by Elsevier in Resuscitation
- Vol. 50 (1), 71-76
- https://doi.org/10.1016/s0300-9572(01)00317-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Myocardial perfusion during cardiopulmonary resuscitation (CPR): effects of 10, 25 and 50% coronary stenosesResuscitation, 1998
- Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: An experimental study in the catIntensive Care Medicine, 1996
- Pre-hospital thrombolytic therapy with either alteplase or streptokinaseEuropean Heart Journal, 1995
- Activation of Blood Coagulation After Cardiac Arrest Is Not Balanced Adequately by Activation of Endogenous FibrinolysisCirculation, 1995
- Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolismThe American Journal of Cardiology, 1992
- Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)Journal of the American College of Cardiology, 1992
- Safety of thrombolysis in association with cardiopulmonary resuscitation.BMJ, 1991
- Thrombolytic therapy in patients requiring cardiopulmonary resuscitationThe American Journal of Cardiology, 1991
- Cardiac arrest and resuscitation: A tale of 29 citiesAnnals of Emergency Medicine, 1990
- Standards and guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC). National Academy of Sciences - National Research CouncilPublished by American Medical Association (AMA) ,1986